Blog

free-event-|-may-31:-get-the-answers-to-your-solopreneur-challenges
Uncategorised

Free Event | May 31: Get the Answers to Your Solopreneur Challenges

Running a one person business is challenging, but we’re here to help you. Tune into our video series, Solopreneur Office Hours, as our expert, Terry Rice, answers your most pressing questions. Running a one person business is challenging, but it doesn’t have to be confusing. In our new series, Office Hours for Solopreneurs with Terry

will-the-next-fed-announcement-be-bullish-or-bearish?
Uncategorised

Will the Next Fed Announcement Be Bullish or Bearish?

Investors have been in a state of limbo all year long trying to determine if still in a bear market or has the new bull already emerged? 4,200 on the S&P 500 (SPY) being the key level. Interestingly, the Fed announcement on Wednesday 5/3 could be the key catalyst to settle this dispute once and

using-fintech-to-optimize-real-estate-investments
Uncategorised

Using FinTech to Optimize Real Estate Investments

Whether you’re a real estate investor, entrepreneur or simply a finance-savvy consumer, financial technology (fintech) has allowed great strides when it comes to optimizing real estate investments. Fintech involves using blockchain, big data, cloud computing or artificial intelligence to complete financial transactions. Most property technology (proptech) overlaps with fintech, allowing real estate agents and investors

can-fite-biopharma-spikes-on-pancreatic-cancer-inhibition-finding
Uncategorised

Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding

Can-Fite BioPharma Ltd. (NYSEAMERICAN: CANF) is an Israel-based biotechnology firm that develops small-molecule therapeutic treatments for cancers, inflammatory diseases and sexual dysfunction. It targets the A3 adenosine receptor (A3AR) and creates small molecule therapies to bind or stick to the A3 receptor and disrupt the growth of pathological cells. The A3AR has been targeted for

ecolab:-slow-and-steady-wins-the-race 
Uncategorised

Ecolab: Slow And Steady Wins The Race 

Ecolab (NYSE: ECL) has had its share of issues over the last 2 years, but those are centered on share prices which have retreated to reasonable levels. The stock soared after COVID-19, driven by the expectation sanitation services and products would be in high demand, but that demand never materialized to the extent that share

mgm’s-hot-hand-is-all-in-for-a-rally,-after-this-small-break
Uncategorised

MGM’s Hot Hand Is All In For A Rally, After This Small Break

The Chinese have a saying concerning the reality of the haves and have-nots and how they should deal with their finances. Those who have riches or inherit them can afford to speculate with small sums of money, while those who do not have wealth and are part of the middle class have to speculate with

high-yield-pfizer-falls-off-the-covid-cliff,-and-survives
Uncategorised

High-Yield Pfizer Falls Off The COVID Cliff, And Survives

Pfizer (NYSE: PFE) was expected to post a significant decline in revenue and earnings because of the slowing COVID business, and it did. However, the takeaway from the report is that business is better than expected, the company is growing at the core level, and the pipeline of new products is robust. That’s important because

5-reasons-why-entrepreneurs-are-privileged
Uncategorised

5 Reasons Why Entrepreneurs Are Privileged

Opinions expressed by Entrepreneur contributors are their own. As a Black woman entrepreneur, I’ve managed to run a successful diversity, equity and inclusion (DEI) consultancy for the past six years. But I promise, it wasn’t easy. For me, becoming an entrepreneur looked like getting a doctorate in organizational leadership and working my way to owning

Scroll to Top